Navigation Links
Florastor(R) Receives ConsumerLab.com Certification
Date:3/11/2008

he enteric protection of the product, meaning the microorganisms' ability to survive as they make their way through stomach acid and into the small intestine where bacteria would flourish.

"Florastor is the most widely used probiotic in the world and is the product of extensive and ongoing research," says Berry. "It is very important to us that its claims have been validated by a reputable third party so that U.S. consumers can have confidence in the product."

Florastor, which utilizes a freeze-dried form of a beneficial yeast called Saccharomyces boulardii (S. boulardii), was voluntarily submitted for ConsumerLab.com testing and passed the organization's review criteria by meeting its listed number of 10 billion probiotic organisms in a maximum suggested daily serving, as well as being free of microbial contamination and exhibiting sufficient enteric protection.

Florastor is supported by numerous clinical studies and is the only probiotic mentioned by the World Health Organization (WHO) for use in managing recurrent disease associated with the Clostridium difficile (C. diff) infection(1). It is clinically proven to be effective in helping to manage intestinal issues ranging from acute diarrhea to chronic inflammatory conditions (such as Crohn's disease or ulcerative colitis). Florastor has also been clinically proven to be particularly effective in combating antibiotic-associated diarrhea, since, unlike bacteria-based probiotics, the beneficial yeast in Florastor cannot be killed by the antibiotic treatment itself.

Probiotics are defined by the Food and Agriculture Organization (FAO) of the United Nations, as "live microorganisms administered in adequate amounts, which confer a beneficial health effect on the host." Florastor has shown in more than 50 years of extensive international use to be safe and effective, with an estimated 1.7 billion daily doses sold to date.

Florastor is available in most retail chain pharmacies, and at
'/>"/>

SOURCE Florastor
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. DuraHeart(TM) LVAS Receives Conditional Approval for US Pivotal Trial
2. Vermillion Receives Award From the Society of Gynecologic Oncologists
3. Arbios Receives Conditional Approval from the FDA to Initiate Pivotal Clinical Trial for SEPET(TM)
4. ActivBiotics Receives Orphan Drug Designation from the European Medicines Agency for Superoxide Dismutase Mimetic, M40403, in Oral Mucositis Indication
5. Thalidomide Pharmion(R) Receives Positive Opinion for Treatment of First-line Multiple Myeloma from European Medicines Agency
6. Peregrine Pharmaceuticals Receives Approval to Conduct a Second Phase II Trial of Bavituximab in Patients With Advanced Breast Cancer
7. Photo: Welchol(TM) (colesevelam HCl) Receives FDA Approval to Reduce Blood Glucose in Adults with Type 2 Diabetes
8. Peregrine Pharmaceuticals Receives Approval to Conduct a Phase II Trial of Bavituximab in Patients With Non-Small Cell Lung Cancer
9. Abbotts HUMIRA(R) (adalimumab) Receives FDA Approval For Moderate to Severe Chronic Plaque Psoriasis
10. Vical Receives Payment from AnGes MG for Allovectin-7(R) Phase 3 Pivotal Trial
11. Fovea Pharmaceuticals Receives Orphan Drug Designation from EC for RdCVF for the Treatment of Retinitis Pigmentosa
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... ,, Reportlinker.com announces that a new market ... ,, Hepatitis B Vaccines - Pipeline ... ,, http://www.reportlinker.com/p0167309/Hepatitis-B-Vaccines---Pipeline-Analysis-and-Market-Forecasts-to-2015.html ,, Hepatitis B ... to 2015 ,, Summary ,, ... "Hepatitis B Vaccines - Pipeline Analysis and ...
(Date:12/15/2009)... Dec. 15 Reportlinker.com announces ... is available in its catalogue: ,, ... assessment of the competitive environment is ... management responsibilities, the task crucial to ... and factual competitive intelligence is vital ...
(Date:12/15/2009)... -- Reportlinker.com announces that a new ... its catalogue: ,, The Future ... to 2015, Competitive Benchmarking, Product Pipeline ... http://www.reportlinker.com/p0168102/The-Future-of-HIV-Therapeutics---Market-Forecasts-to-2015-Competitive-Benchmarking-Product-Pipeline-and-Deals-Analysis.html ,, Summary ... latest research "The Future of HIV ...
Breaking Medicine Technology:Reportlinker Adds Hepatitis B Vaccines - Pipeline Analysis and Market Forecasts to 2015 2Reportlinker Adds Hepatitis B Vaccines - Pipeline Analysis and Market Forecasts to 2015 3Reportlinker Adds Hepatitis B Vaccines - Pipeline Analysis and Market Forecasts to 2015 4Reportlinker Adds Hepatitis B Vaccines - Pipeline Analysis and Market Forecasts to 2015 5Reportlinker Adds Hepatitis B Vaccines - Pipeline Analysis and Market Forecasts to 2015 6Reportlinker Adds Hepatitis B Vaccines - Pipeline Analysis and Market Forecasts to 2015 7Reportlinker Adds Top Ten World's Leading Orthopedics Companies 2Reportlinker Adds Top Ten World's Leading Orthopedics Companies 3Reportlinker Adds The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 2Reportlinker Adds The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 3Reportlinker Adds The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 4Reportlinker Adds The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 5Reportlinker Adds The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 6Reportlinker Adds The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 7Reportlinker Adds The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 8Reportlinker Adds The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 9Reportlinker Adds The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 10Reportlinker Adds The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 11Reportlinker Adds The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 12ISTA Pharmaceuticals Reports Third Quarter 2009 Financial Results 14704 1ISTA Pharmaceuticals Reports Third Quarter 2009 Financial Results 14704 2ISTA Pharmaceuticals Reports Third Quarter 2009 Financial Results 14704 3ISTA Pharmaceuticals Reports Third Quarter 2009 Financial Results 14704 4ISTA Pharmaceuticals Reports Third Quarter 2009 Financial Results 14704 5ISTA Pharmaceuticals Reports Third Quarter 2009 Financial Results 14704 6ISTA Pharmaceuticals Reports Third Quarter 2009 Financial Results 14704 7ISTA Pharmaceuticals Reports Third Quarter 2009 Financial Results 14704 8ISTA Pharmaceuticals Reports Third Quarter 2009 Financial Results 14704 9Sangamo BioSciences Announces Presentation at Merriman Curhan Fords Investor Summit 2009 14701 1Sangamo BioSciences Announces Presentation at Merriman Curhan Fords Investor Summit 2009 14701 2Cancer Diagnostics Company On Q ity Raises 2421M in Series A Funding for the Development of Technologies to Personalize Cancer Therapy 5961 1Cancer Diagnostics Company On Q ity Raises 2421M in Series A Funding for the Development of Technologies to Personalize Cancer Therapy 5961 2
... May 29 Magellan Biosciences, an,emerging leader ... and assays designed to streamline microbiology testing,and ... 108th meeting of the,American Society for Microbiology ... Technologies, will share booth 743 at the,exhibition, ...
... Wyeth,Pharmaceuticals, a division of Wyeth (NYSE: ... Drug Administration (FDA) has issued an approvable letter ... of,adult patients with community-acquired pneumonia (CAP)., Before ... analyses to support the safety and efficacy of ...
Other Medicine Technology:Magellan Biosciences Companies to Feature Automated Products and New Tests for MRSA at the American Society for Microbiology Meeting, Booth 743 2Magellan Biosciences Companies to Feature Automated Products and New Tests for MRSA at the American Society for Microbiology Meeting, Booth 743 3Wyeth Receives Approvable Letter from FDA for TYGACIL for the Treatment of Patients with Community-Acquired Pneumonia 2Wyeth Receives Approvable Letter from FDA for TYGACIL for the Treatment of Patients with Community-Acquired Pneumonia 3Wyeth Receives Approvable Letter from FDA for TYGACIL for the Treatment of Patients with Community-Acquired Pneumonia 4Wyeth Receives Approvable Letter from FDA for TYGACIL for the Treatment of Patients with Community-Acquired Pneumonia 5Wyeth Receives Approvable Letter from FDA for TYGACIL for the Treatment of Patients with Community-Acquired Pneumonia 6
(Date:12/15/2009)... Dec. 15 Reportlinker.com announces ... is available in its catalogue: ,, ... Diseases Therapeutics - Market Forecasts to ... Deals Analysis ,, ... ,, The author has released its ...
(Date:12/15/2009)... Dec. 15 Today, Coastal Healthcare ... Clara County for the first time since ... Coastal Healthcare Administrators will be assuming responsibilities ... Physicians Foundation for Medical Care. ,, ... Coastal maintains close working relationships with all ...
(Date:12/15/2009)... to be the major form of the virus in ... Program (MHRP) researchers, however, have demonstrated that essentially all ... surface of red blood cells isolated from each of ... today in PLoS ONE , and can be ... Beck and Dr. Carl Alving, researchers with MHRP in ...
(Date:12/15/2009)... 2009Do good-looking people really benefit from their looks, and ... University of Georgia and the University of Kansas found ... social relationships and therefore an increased sense of psychological ... why we spend billions of dollars each year trying ... this month,s issue of Personal Relationships , also ...
(Date:12/15/2009)... Synthetic Fillers and Large Volume Injections Dangerous , ... ... -- The popularity and hype surrounding buttock augmentation and other ... outside U.S. borders is an alarming and potentially deadly trend, ... Permanent fillers such as polymethylmethacrylate (PMMA), silicone, and polyacrylimide used ...
Breaking Medicine News(10 mins):Health News:Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 2Health News:Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 3Health News:Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 4Health News:Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 5Health News:Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 6Health News:Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 7Health News:Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 8Health News:Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 9Health News:Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 10Health News:Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 11Health News:Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 12Health News:Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 13Health News:Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 14Health News:Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 15Health News:Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 16Health News:Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 17Health News:Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 18Health News:Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 19Health News:Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 20Health News:Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 21Health News:Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 22Health News:Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 23Health News:Coastal Healthcare Administrators Expands Provider Network to Santa Clara County 2Health News:The importance of attractiveness depends on where you live 2Health News:Physicians Coalition for Injectable Safety Warns Buttock-Boosting Injections Risky and Deadly 2Health News:Physicians Coalition for Injectable Safety Warns Buttock-Boosting Injections Risky and Deadly 3Health News:Physicians Coalition for Injectable Safety Warns Buttock-Boosting Injections Risky and Deadly 4
... Oak Brook , ... and the March of Dimes invites nurses, midwives, nurse practitioners, clinical ... the March of Dimes 34th Annual Perinatal Conference February 25-27th at ... professionals caring for moms and babies are urged to attend. , ...
... most common in India, leaves carriers with little warning of ... million people worldwide carry a gene mutation that almost always ... people in India, according to a study by 25 researchers ... of death in the world. By 2010, India will account ...
... have higher concentrations of folate in their blood than individuals ... at the University of California, San Francisco and UC Berkeley. ... patients with IBD are prone to folate also known ... that opens the door to additional research into the role ...
... condition has dropped , , FRIDAY, Jan. 23 (HealthDay News) ... distress syndrome (ARDS) hasn,t changed since 1994, according to ... a steady decline in the percentage of ARDS patients ... 1984 and 2006, and found the death rate for ...
... CALL TO ACTIONWASHINGTON, Jan. 23 The ... this country participating in volunteer events on Monday,s Martin ... the most popular Red Cross events were giving blood ... Ready." , , (Logo: http://www.newscom.com/cgi-bin/prnh/20090108/RedCrossLOGO ...
... AURORA, N.Y., Jan. 23 Moog Inc. (NYSE: MOG.A; ... of Ethox International for $15.2 million in cash. Ethox ... service provider. The company produces proprietary medical devices ... many of the industry,s leading medical device companies. Ethox ...
Other Medicine News:Health News:March of Dimes 34th Annual Perinatal Conference For Nurses, Health Educators, Social Workers and Other Healthcare Pros Caring for Moms and Babies 2Health News:60 Million Worldwide Carry Heart Disease Mutation 2Health News:Children with inflammatory bowel disease have surprisingly high folate levels, study finds 2Health News:Children with inflammatory bowel disease have surprisingly high folate levels, study finds 3Health News:Acute Respiratory Distress Syndrome as Deadly as Ever 2Health News:Red Cross: Records Set On Day of Service 2Health News:Moog Acquires Buffalo-Based Ethox International 2Health News:Moog Acquires Buffalo-Based Ethox International 3Health News:Moog Acquires Buffalo-Based Ethox International 4
Inquire...
500L...
... precision, ergonomics, and value!, Comfortable ... soft non-slip, contoured handle , Finer ... plunger spring action , Completely autoclavable ... the need for recalibration , Easy-to-read ...
Inquire...
Medicine Products: